Laparoscopic sleeve gastrectomy versus laparoscopic Roux-en-Y gastric bypass. A systematic review and meta-analysis of weight loss, comorbidities, and biochemical outcomes from randomized controlled trials. Ann Surg 2021; 273: 66-74.
Published: 7th April 2021
Authors: Lee Y, Doumouras A, Yu J, Aditya I, Gmora S, Anvari M et al.
Some 33 RCTs involving 2457 patients were analyzed. Roux-en-Y bypass resulted in greater loss of body mass (mean difference 1.25Kg, P=0.001), which persisted to three years. It also was more likely to resolve dyslipidaemia after one year (P<0.001), but effects on diabetes and hypertension were similar.Pubmed Link
You may also be interested in
Banded versus nonbanded sleeve gastrectomy. A randomized controlled trial with 3 years of follow-up. Ann Surg 2020; 272: 690-695.
Authors: Fink J, Hetzenecker A, Seifert G, Runkel M, Laessle C, Fichtner-Feigl S et al.
Efficacy and safety of the duodeno-jejunal bypass liner in patients with metabolic syndrome. A multicenter randomized controlled trial (ENDOMETAB). Ann Surg 2020; 272: 696-702.
Authors: Caiazzo R, Branche J, Raverdy V, Czernichow S, Carette C, Robert M et al.
Efficacy of transversus abdominis plane (TAP) block in pain management after laparoscopic sleeve gastrectomy (LSG): A double-blind randomized controlled trial. Am J Surg 2019; 217: 126-132.
Authors: Saber AA, Lee YC, Arjun C, Namik O, Armand A, Al-Ayoubi S et al.
Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial. Lancet 2019; 393: 1299-1309.
Authors: Maud R, Espalieu P, Pelascini E, Caiazzo R, Sterkers A, Khamphommala L et al.
Effectiveness of fibrin sealant application on the development of staple line complications after sleeve gastrectomy: a prospective randomized trial. Ann Surg 2018; 268: 762-768.
Authors: Rebibo L, Dhahri A, Chati R, Cosse C, Huet E, Regimbeau J-M et al.
Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity. The SM-BOSS randomized clinical trial. JAMA 2018; 319: 255-265.
Authors: Peterli R, Wölnerhanssen BK, Peters T, Vetter D, Kröll D , Borbély Y et al.
Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss at 5 years among patients with morbid obesity. The SLEEVEPASS randomized clinical trial. JAMA 2018; 319: 241-254.
Authors: Salminen P, Helmiö M, Ovaska J, Juuti A, Leivonen M, Peromaa-Haavisto P et al.
Laparoscopic sleeve gastrectomy versus Roux-Y-gastric bypass for morbid obesity: 3-year outcomes of the prospective randomized Swiss Multicenter Bypass Or Sleeve Study (SM-BOSS). Ann Surg 2017; 265: 466-473.
Authors: Peterli R, Wölnerhanssen BK, Vetter D, Nett P, Gass M, Borbély Y et al.
Standard vs distal Roux-en-Y gastric bypass in patients with body mass index 50 to 60. A double-blind, randomized clinical trial. JAMA Surg 2016; 151: 1146-1155.
Authors: Risstad H, Svanevik M, Kristinsson JA, Hjelmesæth J, Aasheim T, Hofsø D et al.
Impact of surgical technique on long-term complication rate after laparoscopic adjustable gastric banding (LAGB): results of a single-blinded randomized controlled trial (ANOSEAN Study). Ann Surg 2016; 264: 738-744.
Authors: Le Coq B, Frering V, Ghunaim M, Campan P, Dabrowski A, Mulliez E et al.
Closure of mesenteric defects in laparoscopic gastric bypass: a multicentre, randomised, parallel, open-label trial. Lancet 2016; 387: 1397–1404.
Authors: Stenberg E, Szabo E, Ågren G, Ottosson J, Marsk R, Lönroth H et al.
Three-year outcomes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment. A randomized clinical trial. JAMA Surg 2015; 150: 931-940.
Authors: Courcoulas AP, Belle SH, Neiberg RH, Pierson SK, Eagleton JK, Kalarchian MA et al. et al.